ERC-AG-LS4
ERC-AG-LS4
Programme: H2020
66 projects · €161,684,626 total EU contribution (project-level) · 53 participating organizations · 14 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€161,684,626
Countries active
Participant organizations by country (headquarters in CORDIS).
- UK (12)
- Germany (8)
- France (5)
- Italy (5)
- CH (4)
- Spain (4)
- SE (3)
- AT (2)
- FI (2)
- IL (2)
- Netherlands (2)
- DK (1)
- EL (1)
- LB (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- KI5 projects · SE
- EPFL4 projects · CH
- IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE4 projects · UK
- HELSINGIN YLIOPISTO3 projects · FI
- INSERM3 projects · FR
- THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE3 projects · UK
- ETH Zürich2 projects · CH
- IRB BARCELONA - CERCA2 projects · ES
- FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III2 projects · ES
- .2 projects · IT
- IMBA2 projects · AT
- ISTITUTO EUROPEO DI ONCOLOGIA SRL2 projects · IT
Projects
Page 2 of 7
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Targeting RAS oncogene addiction RASTARGET · 323145 | FP7 | €2,496,221 | €2,496,221 | Details |
Pre-receptor cortisol metabolism and human ageing PRECORT · 250271 | FP7 | €2,499,760 | €2,499,760 | Details |
New mechanisms of angiogenesis modulators in switching between white and brown adipose tissues ANGIOFAT · 250021 | FP7 | €2,411,547 | €2,411,547 | Details |
Development and application of global lipidomic arrays to inflammatory vascular disease LIPIDARRAY · 339129 | FP7 | €2,969,345 | €2,969,345 | Details |
Enzymatic and genomic targets of histone modifying enzymes and their role in liver metabolism and hepatocarcinogenesis SET-NET · 294464 | FP7 | €2,499,600 | €2,499,600 | Details |
Epigenetic Disruption of Non-Coding RNAs in Human Cancer EPINORC · 268626 | FP7 | €2,497,240 | €2,497,240 | Details |
Redox sensing and signalling in cardiovascular health and disease CARDIOREDOX · 339095 | FP7 | €2,255,659 | €2,255,659 | Details |
Metabolic consequences of mitochondrial dysfunction METABOMIT · 268955 | FP7 | €2,500,000 | €2,500,000 | Details |
The Dependence Receptors notion: from a cell biology paradigm to anti-cancer targeted therapy DEPREC · 294079 | FP7 | €2,485,037 | €2,485,037 | Details |
ATP-sensitive potassium channels: from atomic structure to human disease KATP-DIABETES · 322620 | FP7 | €2,478,420 | €2,478,420 | Details |